Jacque Sokolov
Arizona Advisory Board Co-Chair
Jacque J. Sokolov, MD, is founder, chairman, and chief executive officer of the SSB, a diversified U.S.-based healthcare management, development, and investment company. As CEO, Dr. Sokolov leads the four strategic business units to optimize solutions, investment strategies, financial structures, and governmental contracting.
Dr. Sokolov and the SSB teams have been vital to large healthcare corporations to reimagine their business models and improve and increase performance at critical inflection points in their history. Some of his projects include redesigning large health plans such as the Humana Inc. turnaround in 2000 and the transition of Hospira from an IV solution company to the largest independent biosimilar manufacture in the world that Pfizer acquired for $17 billion in 2015. In addition, Dr. Sokolov remains active in the development of physician practice management companies such as the Summit Medical Group and CityMD transaction by Warburg Pincus in 2019. Lastly, the firm remains involved in advanced telehealth companies such as GlobalMed and next-generation immunosignature/immunotherapy companies such as Calviri.
Upon starting his career, Dr. Sokolov served as vice president of Healthcare and chief medical officer for Southern California Edison where he restructured one of the largest self-funded, self-administered corporate ERISA plans in the United States. The restructured SCE Health Plan is similar to the HAVEN healthcare venture between Amazon, J.P. Morgan, and Berkshire Hathaway. Dr. Sokolov’s plan cut spending by $100 million and improved healthcare quality for SCE employees/retirees. He currently serves on multiple public, private, and not-for-profit healthcare boards.
Dr. Sokolov is a 2022 NACD Directorship 100 honoree. He received his BA and MD degrees from the University of Southern California and completed his internal medicine residency at the Mayo Graduate School of Medicine followed by his fellowship in cardiovascular diseases/nuclear cardiology from the University of Texas-Southwestern Medical School.